C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 211/60 (2006.01) A61K 31/395 (2006.01) C07D 203/08 (2006.01) C07D 203/10 (2006.01) C07D 207/16 (2006.01) C07D 211/22 (2006.01) C07D 211/52 (2006.01) C07D 211/62 (2006.01) C07D 211/78 (2006.01) C07D 215/48 (2006.01) C07D 217/26 (2006.01) C07D 241/04 (2006.01) C07D 243/08 (2006.01) C07D 265/30 (2006.01) C07D 295/15 (2006.01) C07D 295/205 (2006.01)
Patent
CA 2217194
A compound of formula (1), in which Z is selected from (a), (b), (c), (d), (e), (f), (g), (h), (i), (j) and (k). The present invention relates to novel N-substituted azaheterocyclic carboxylic acids and esters thereof in which a substituted alkyl chain forms part of the N-substituent or salts thereof, to methods for their preparation, to composition containing them, and to their use for the clinical treatment of painful, hyperalgesic and/or inflammatory conditions in which C-fibers play a pathophysiological role by eliciting neurogenic pain or inflammation.
La présente invention se rapporte à un composé de formule (I). Z est sélectionné parmi (a), (b), (c), (d), (e), (f), (g), (h), (i), (j) et (k). L'invention concerne de nouveaux acides carboxyliques azahétérocycliques N-substitués et leurs esters, dans lesquels une chaîne alkyle substitutée fait partie du substituant N ou de ses sels, leur procédé de fabrication, des compositions les contenant et leur utilisation pour le traitement clinique d'états douloureux, hyperalgésiques et/ou inflammatoires dans lesquelles les fibres C jouent un rôle pathophysiologique en provoquant une douleur ou inflammation neurogène.
Alexandra Silhankova
Andersen Henrik Sune
Andersen Knud Erik
Hohlweg Rolf
Jorgensen Tine Krogh
Mccarthy Tetrault Llp
Novo Nordisk A/s
LandOfFree
Novel heterocyclic compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel heterocyclic compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel heterocyclic compounds will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1668748